Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Securities and Exchange Commission v. Applied BioSciences Corp.
Case Number:
1:20-cv-03729
Court:
Nature of Suit:
Judge:
Government Agencies
-
October 28, 2020
SEC Settles Suit Over Allegedly Misleading COVID-19 Claims
The U.S. Securities and Exchange Commission has reached a tentative deal to settle its suit in New York federal court accusing a company of making misleading statements about the availability of at-home COVID-19 tests.
-
June 01, 2020
COVID-19 Securities Catch-Up: SEC Enforcement
As the coronavirus pandemic pushes into the summer, Law360 is taking a look at the enforcement actions and trading suspensions the SEC has issued in connection with the virus since it captured the public consciousness earlier this year.
-
May 14, 2020
SEC Targets 2 Cos. Over Misleading COVID-19 Claims
The U.S. Securities and Exchange Commission took aim at two unrelated companies that purported to offer products to combat COVID-19, accusing them of defrauding the public and artificially inflating their share prices in separate enforcement actions filed Wednesday and Thursday.